Silver Book Fact

HVD patients knew little prior to their diagnosis

More than 2/3 of valve disease patients knew a limited amount or nothing about heart valve disease (HVD) before their diagnosis.

Report of Findings from Opinion Research among Heart Valve Disease Patients. http://www.agingresearch.org/backend/app/webroot/files/Publication/370/Research%20Opinion%20Survey%20among%20Heart%20Valve%20Patients_Final.pdf. Published 2016. Accessed October 16, 2017

Related Facts

  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Hospital Discharges from Heart Valve Disease in 2010*
     
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…